Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization

Tsutomu Watanabe, Hiroko Suzuya, Toshihiro Onishi, Sachiyo Kanai, Michiya Kaneko, Hiroyoshi Watanabe, Ryuji Nakagawa, Yoshifumi Kawano, Yoichi Takaue, Yasuhiro Kuroda, James E Talmadge

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.

Original languageEnglish (US)
Pages (from-to)75-81
Number of pages7
JournalInternational Journal of Hematology
Volume77
Issue number1
DOIs
StatePublished - Jan 2003

Fingerprint

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Bone and Bones
Osteoprotegerin
Serum
Osteocalcin
Alkaline Phosphatase
Urine
Bone Resorption
Creatinine
Peripheral Blood Stem Cells
Macrophage Colony-Stimulating Factor
Transforming Growth Factors
Interleukin-1
Osteogenesis
Interferons
Interleukin-6
Tumor Necrosis Factor-alpha
Biomarkers

Keywords

  • Bone metabolism
  • G-CSF
  • Mobilization
  • Peripheral blood stem cells

ASJC Scopus subject areas

  • Hematology

Cite this

Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. / Watanabe, Tsutomu; Suzuya, Hiroko; Onishi, Toshihiro; Kanai, Sachiyo; Kaneko, Michiya; Watanabe, Hiroyoshi; Nakagawa, Ryuji; Kawano, Yoshifumi; Takaue, Yoichi; Kuroda, Yasuhiro; Talmadge, James E.

In: International Journal of Hematology, Vol. 77, No. 1, 01.2003, p. 75-81.

Research output: Contribution to journalArticle

Watanabe, T, Suzuya, H, Onishi, T, Kanai, S, Kaneko, M, Watanabe, H, Nakagawa, R, Kawano, Y, Takaue, Y, Kuroda, Y & Talmadge, JE 2003, 'Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization', International Journal of Hematology, vol. 77, no. 1, pp. 75-81. https://doi.org/10.1007/BF02982606
Watanabe, Tsutomu ; Suzuya, Hiroko ; Onishi, Toshihiro ; Kanai, Sachiyo ; Kaneko, Michiya ; Watanabe, Hiroyoshi ; Nakagawa, Ryuji ; Kawano, Yoshifumi ; Takaue, Yoichi ; Kuroda, Yasuhiro ; Talmadge, James E. / Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. In: International Journal of Hematology. 2003 ; Vol. 77, No. 1. pp. 75-81.
@article{0a548372bbf9419eb4f86e215278a3f4,
title = "Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization",
abstract = "Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.",
keywords = "Bone metabolism, G-CSF, Mobilization, Peripheral blood stem cells",
author = "Tsutomu Watanabe and Hiroko Suzuya and Toshihiro Onishi and Sachiyo Kanai and Michiya Kaneko and Hiroyoshi Watanabe and Ryuji Nakagawa and Yoshifumi Kawano and Yoichi Takaue and Yasuhiro Kuroda and Talmadge, {James E}",
year = "2003",
month = "1",
doi = "10.1007/BF02982606",
language = "English (US)",
volume = "77",
pages = "75--81",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization

AU - Watanabe, Tsutomu

AU - Suzuya, Hiroko

AU - Onishi, Toshihiro

AU - Kanai, Sachiyo

AU - Kaneko, Michiya

AU - Watanabe, Hiroyoshi

AU - Nakagawa, Ryuji

AU - Kawano, Yoshifumi

AU - Takaue, Yoichi

AU - Kuroda, Yasuhiro

AU - Talmadge, James E

PY - 2003/1

Y1 - 2003/1

N2 - Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.

AB - Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.

KW - Bone metabolism

KW - G-CSF

KW - Mobilization

KW - Peripheral blood stem cells

UR - http://www.scopus.com/inward/record.url?scp=0038651197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038651197&partnerID=8YFLogxK

U2 - 10.1007/BF02982606

DO - 10.1007/BF02982606

M3 - Article

C2 - 12568303

AN - SCOPUS:0038651197

VL - 77

SP - 75

EP - 81

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -